Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients.
Ontology highlight
ABSTRACT: The value of adjuvant chemotherapy in elderly patients has been the subject of many overviews, with opinions varying from "not effective", since randomized trials have not been performed, to "as effective as in young individuals", based upon many retrospective analyses of randomized trials that have included patients of all ages. In the absence of randomized trials performed specifically with elderly patients, retrospective analyses demonstrate that the influence on the time to tumour recurrence (TTR) may be the same as in young individuals, but that endpoints that include death for any reason, such as recurrence-free survival (RFS), disease-free survival (DFS), and overall survival (OS), are poorer in the elderly. This is particularly true if oxaliplatin has been part of the treatment. Th
SUBMITTER: Glimelius B
PROVIDER: S-EPMC7464071 | biostudies-literature | 2020 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA